0:00
16:38
SGLT2 inhibitors and GLP-1 receptor agonists now have well-established cardiovascular and renal benefits. What does this mean for their role in the management of type 2 diabetes? Justin Coleman chats with endocrinologist and clinical pharmacologist, Tilenka Thynne, about this and other updates to Therapeutic Guidelines Diabetes.
Weitere Episoden von „Australian Prescriber Podcast“
Verpasse keine Episode von “Australian Prescriber Podcast” und abonniere ihn in der kostenlosen GetPodcast App.